Biotech Company GangaGen raises $1.8mn

Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.

The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)

Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!

Also:

• • Tech

Moore’s Law Is DEAD. RIP.

• NextBigWhat
• October 15, 2019

• • Tech

Consumption slowdown started with note ban: RBI

• NextBigWhat
• September 8, 2019

• • Tech

What I have learnt as a teacher

• Ashish Sinha
• September 5, 2019

• • Tech

Note to Lambda School Clones in India: There is a Much Bigger Opportunity than Cloning

• Ashish Sinha
• August 30, 2019